Publications by authors named "N Robert"

The urgency of addressing climate change, exacerbated by greenhouse gas emissions, necessitates sustainable solutions, including green building practices and renewable energy adoption. This study focuses on the feasibility of implementing solar photovoltaic systems at Universitas Multimedia Nusantara (UMN), particularly in Building C, known as the New Media Tower, which is designed with green building principles. Solar energy, an increasingly prominent renewable source, presents a viable solution to reduce carbon footprints.

View Article and Find Full Text PDF

Introduction: To better understand the SDOH-health equity landscape within a community oncology setting to answer the research question, "Which SDOH can have the highest impact in community oncology to advance patient care equity and improve health outcomes?"

Methods: Arksey and O'Malley's scoping review framework was used to identify evidence related to SDOH and health equity in community oncology. The study was guided by the "10-Step Framework for Continuous Patient Engagement" and a Community Advisory Board to assure relevance to patients and community providers. Literature was retrieved from literary databases and oncology organizations' websites.

View Article and Find Full Text PDF

presents a single nucleotide polymorphism at location 158 (V/F), which affects its binding to the fragment crystallizable (Fc) of antibodies (Abs). FcγRIIIa-158 V allotype has the highest affinity and is associated with a better clinical response to IgG1 monoclonal Abs (mAb) treatment. We compared the allele frequency of F158V polymorphism in cohorts of patients with B-cell lymphoproliferative disorders, including multiple myeloma (MM), monoclonal gammopathy of undetermined significance (MGUS), non-Hodgkin lymphoma (NHL), and B-cell chronic leukemia (B-CLL).

View Article and Find Full Text PDF
Article Synopsis
  • - The collaboration aimed to analyze real-world data (RWD) to better understand treatment responses in metastatic non-small cell lung cancer (mNSCLC) patients, particularly focusing on the challenges of assessing real-world treatment outcomes.
  • - A retrospective observational study was conducted using data from several electronic health record companies that included information from 200 patients treated with a standard chemotherapy protocol, assessing key response metrics such as real-world response rate and overall survival.
  • - Results indicated that while clinician assessments were consistent across data sources, there was variability in imaging data and the duration of response; overall, the study confirmed the potential to harmonize diverse data sources for evaluating treatment responses in mNSCLC patients.
View Article and Find Full Text PDF